leading glp-1 treatments for diabetes 2025 Impact: How GLP-1s Are Changing the Treatment Paradigm Diabetes Care Market Leaders Emerging

Seriously, 10/10

Not suitable for those monitoring blood sugar or trying to avoid glucose spikes

Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease

Huang, J

To determine the drugs effect on the brain, the team mimicked stress in mouse models

Individuals were also ineligible if they had any contraindications to study treatment or if, in the opinion of the investigator, they had any other medical condition, clinically significant laboratory result or electrocardiogram findings that may compromise safety or compliance, preclude the participant from successful study completion or interfere with interpretation of results